Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan

Tetsuhiro Tanaka; Masaomi Nangaku; Enyu Imai; Yoshiharu Tsubakihara; Masatoshi Kamai; Michihito Wada; Shinji Asada; Tadao Akizawa

doi:10.1007/s10157-019-01694-w

Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan

Clin Exp Nephrol. 2019 Mar;23(3):435. doi: 10.1007/s10157-019-01694-w.

Authors

Tetsuhiro Tanaka¹, Masaomi Nangaku¹, Enyu Imai², Yoshiharu Tsubakihara³, Masatoshi Kamai⁴, Michihito Wada⁵, Shinji Asada⁶, Tadao Akizawa⁷

Affiliations

¹ Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
² Internal Medicine of Nakayamadera Imai Clinic, Takarazuka, Hyogo, Japan.
³ Graduate School of Health Care Sciences, Jikei Institute, Yodogawa-ku, Osaka, Japan.
⁴ Pharmacovigilance Department, Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo, Japan.
⁵ Medical Affairs Department, Kyowa Hakko Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
⁶ Medical Affairs Department, Kyowa Hakko Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. shinji.asada@kyowa-kirin.co.jp.
⁷ Showa University, Shinagawa-ku, Tokyo, Japan.

Abstract

In the original publication of the article, two sentences in the "Results" section were published incorrectly. The corrected texts are provided below.

Publication types

Published Erratum